Sensitivity of Sniffer Dogs for a Diagnosis of Parkinson's Disease: A Diagnostic Accuracy Study.
Chang-Qing Gao,Shan-Ni Wang,Mei-Mei Wang,Jing-Jing Li,Jiao-Jiao Qiao,Juan-Juan Huang,Xu-Xiang Zhang,Ya-Qin Xiang,Qian Xu,Jun-Ling Wang,Zheng-Hua Liu,Jian-Gang Wang,Zhi-Heng Chen,Ping-An Hu,Zhi Song,Shao-Juan Gu,Ru-Xu Zhang,Li-Fang Lei,Ke-Bin Zhan,Yi-Ting Long,Yang Zhang,Min Ye,Zhe Zhong,Yun-Bo Liu,Chen Zhang,Zheng-Ming He,Xiang Fang,Jian-Guo Peng,Chun-Yu Wang,Hui Xu,Bing-Hua Xia,Lu Shen,Bei-Sha Tang,Cui-Wei Zheng,Ya-An Li,Ji-Feng Guo
DOI: https://doi.org/10.1002/mds.29180
IF: 9.698
2022-01-01
Movement Disorders
Abstract:ABSTRACTBackgroundThe diagnostic criteria for Parkinson's disease (PD) remain complex, which is especially problematic for nonmovement disorder experts. A test is required to establish a diagnosis of PD with improved accuracy and reproducibility.ObjectiveThe study aimed to investigate the sensitivity and specificity of tests using sniffer dogs to diagnose PD.MethodsA prospective, diagnostic case‐control study was conducted in four tertiary medical centers in China to evaluate the accuracy of sniffer dogs to distinguish between 109 clinically established medicated patients with PD, 654 subjects without PD, 37 drug‐naïve patients with PD, and 185 non‐PD controls. The primary outcomes were sensitivity and specificity of sniffer dog's identification.ResultsIn the study with patients who were medicated, when two or all three sniffer dogs yielded positive detection results in a sample tested, the index test sensitivity, specificity, and positive and negative likelihood ratios were 91% (95% CI: 84%–96%), 95% (95% CI: 93%–97%), and 19.16 (95% CI: 13.52–27.16) and 0.10 (95% CI: 0.05–0.17), respectively. The corresponding sensitivity, specificity, and positive and negative likelihood ratios in patients who were drug‐naïve were 89% (95% CI: 75%–96%), 86% (95% CI: 81%–91%), and 6.6 (95% CI: 4.51–9.66) and 0.13 (95% CI: 0.05–0.32), respectively.ConclusionsTests using sniffer dogs may be a useful, noninvasive, fast, and cost‐effective method to identify patients with PD in community screening and health prevention checkups as well as in neurological practice. © 2022 International Parkinson and Movement Disorder Society.